pharmaceutical investing Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen's North American Expansion
